Volume 6, Issue 5

HBV: New Data About Barriers To Care

In this issue:

Although expert guidance is widely available to help clinicians identify and manage patients infected with the hepatitis B virus (HBV), existing patient, provider, and health system barriers continue to impede HBV elimination and treatment efforts.

In this issue, Dr. Mandana Khalili and Dr. Michele Tana from the University of California, San Francisco, analyze the recent literature describing the extent of these barriers and the recent investigations into how they may be overcome.

Learning objectives:

  • Discuss patient factors influencing HBV screening and potential strategies to address them.
  • Summarize provider and health care system factors that influence HBV testing and management.
  • Describe gaps in HBV testing and vaccination in specific populations, such as women of childbearing age and pregnancy, and the underserved.


Mandana Khalili, MD
Mandana Khalili, MD

University of California, San Francisco
Professor of Medicine and
Chief of Clinical Hepatology
San Francisco General Hospital
San Francisco, C.A. 

Michele Tana, MD
Michele Tana, MD

University of California, San Francisco
Assistant Professor, Gastroenterology
San Francisco General Hospital
San Francisco, C.A. 

Program Directors:

Mark S. Sulkowski, MD

Professor of Medicine
Division of Infectious Diseases
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology and Hepatology
Johns Hopkins School of Medicine
Baltimore, Maryland

Raymond T. Chung, MD

Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Taryn Haselhuhn, BA, BSN, MSN, CRNP

The Johns Hopkins Hospital
​Baltimore, Maryland

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: February 25, 2019
Expiration date: February 24, 2021